Evidence map›Paper›PMID 41272602›Full record

ArticleBMC cancer2025

The socioeconomic environment and access to care affect the survival of patients with hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Thomas Chaigneau, Olivier Dejardin, Thi Thu Nga Nguyen, Anne-Marie Bouvier, Josephine Gardy, Florence Molinie, Jean-Baptiste Nousbaum, Laure Tron, Benoit Dupont, Arnaud Alves and 4 more

Abstract read
In one paragraph

Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Thomas ChaigneauDepartment of Hepatogastroenterology, Caen University Hospital, Avenue de La Côte de Nacre, Caen, 14000, France. chaigneau-t@chu-caen.fr.
Olivier Dejardin'ANTICIPE' U1086 INSERM-UCN, Caen University Hospital, Avenue de La Côte de Nacre, Caen, 14000, France.
Thi Thu Nga NguyenDepartment of Hepatogastroenterology, Caen University Hospital, Avenue de La Côte de Nacre, Caen, 14000, France.
Anne-Marie BouvierFRANCIM Network (French National Network of Cancer Registries), Toulouse, 31000, France.
Josephine GardyDigestive Cancer Registry of Calvados, Caen University Hospital, Avenue de La Côte de Nacre, Caen, 14000, France.
Florence MolinieFRANCIM Network (French National Network of Cancer Registries), Toulouse, 31000, France.
Jean-Baptiste NousbaumFRANCIM Network (French National Network of Cancer Registries), Toulouse, 31000, France.
Laure TronHepato-Gastroenterology and Digestive Oncology Department, Digidune, Grenoble Alpes University Hospital, La Tronche, France.
Benoit DupontDepartment of Hepatogastroenterology, Caen University Hospital, Avenue de La Côte de Nacre, Caen, 14000, France.
Arnaud Alves'ANTICIPE' U1086 INSERM-UCN, Caen University Hospital, Avenue de La Côte de Nacre, Caen, 14000, France.
Guy Launoy'ANTICIPE' U1086 INSERM-UCN, Caen University Hospital, Avenue de La Côte de Nacre, Caen, 14000, France.
Veronique Bouvier'ANTICIPE' U1086 INSERM-UCN, Caen University Hospital, Avenue de La Côte de Nacre, Caen, 14000, France.
Isabelle Ollivier-HourmandDepartment of Hepatogastroenterology, Caen University Hospital, Avenue de La Côte de Nacre, Caen, 14000, France.
FRANCIM Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe socioeconomic environment and access to care may influence the prognosis of patients with primary liver cancer. We aimed to study the effects of the socioeconomic environment and access to care on the net survival of patients with hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (iCCA).

methodsAll patients with HCC or iCCA who were diagnosed between 2013 and 2015 within the French network of cancer registries were included, with follow-up until June 2018. The socioeconomic environment and access to care were assessed using the European Deprivation Index and the Spatial Accessibility Multiscalar (SCALe) index. The excess hazard ratios (EHR) were estimated and modelled using flexible parametric survival models with multidimensional penalized splines.

resultsIn total, 6137 patients were included (4931 with HCC and 1206 with iCCA). The 5-year net survival rates for men and women with HCC were 19.7% (95% confidence interval (CI) [18.1; 21.3]) and 20.0% (95% CI [16.2; 24.1]), respectively, and the 5-year net survival rates for men and women with iCCA were 10.4% (95% CI [7.5;14.0]) and 10.3% (95% CI [7.4;13.8]), respectively. A socioeconomic gradient was identified between the most and the least deprived areas for men with HCC (EHR 1.16 (95% CI [1.04;1.29]). Difficult access to care negatively affected the net survival of women with HCC (EHR 1.36 (95% CI [1.10;1.68]) corresponding to the 3rd quintile of distribution) and women with iCCA (EHR 1.37 (95% CI [1.07;1.76]) for the most isolated quintile compared with the least isolated quintile).

conclusionsThis study provides distinct net survival analyses for patients with HCC and iCCA. The net survival of patients with HCC is twice as high as that of patients with iCCA. The social environment adversely affects the net survival of men with HCC, whereas the geographical environment adversely affects that of women with HCC and iCCA.

Indexed as

Bile Duct NeoplasmsCarcinoma, HepatocellularCholangiocarcinomaHealth Services AccessibilityLiver NeoplasmsAdultAgedFemaleFranceHumansMaleMiddle AgedPrognosisRegistriesSocioeconomic FactorsSurvival RateAccess to careHepatocellular carcinomaIntrahepatic cholangiocarcinomaNet survivalSocioeconomic environment

Identifiers

PMID41272602
PMCPMC12751342

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.